Targeting the renin–angiotensin system for the reduction of cardiovascular outcomes in hypertension: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers

By Kjeldsen Sverre E   Lyle Paulette A   Tershakovec Andrew M   Devereux Richard B   Oparil Suzanne   Dahlöf Björn   de Faire Ulf   Fyhrquist Frej   Ibsen Hans   Kristianson Krister   Lederballe-Pedersen Ole   Lindholm Lars H   Nieminen Markku S   Omvik Per   Wedel Hans  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 4, 2005-11 ,pp. : 729-745

Informa Healthcare

Access to resources Recommend Favorite

Hematocrit-lowering Effect Following Inactivation of Renin-Angiotensin System with Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers

By  

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 4, 2004-02 ,pp. : 483-486

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic targeting of the angiotensin-converting enzyme 2/Angiotensin-(1-7)/Mas cascade in the renin–angiotensin system: a patent review

By Ferreira Anderson J   Bader Michael   Santos Robson AS  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 5, 2012-05 ,pp. : 567-574

Informa Healthcare

Access to resources Recommend Favorite

Blockade of angiotensin converting enzyme but not of angiotensin AT 1 receptors improves glucose tolerance

By Chow L.   De Gasparo M.   Levens N.  

European Journal of Pharmacology, Vol. 319, Iss. 1, 1997-01 ,pp. : 77-83

Elsevier

Access to resources Recommend Favorite

Inhibition of the renin-angiotensin system and cardio-renal protection: focus on losartan and angiotensin receptor blockade

By Parvanova Aneliya   Chiurchiu Carlos   Ruggenenti Piero   Remuzzi Giuseppe  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 11, 2005-09 ,pp. : 1931-1942

Informa Healthcare

Access to resources Recommend Favorite